The notices it replaced
- Reissues: PAR-18-646 Opportunities for Collaborative Research at the NIH Clinical Center (U01 - Clinical Trial Optional)
- 2 steps back: PAR-15-287 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
- 3 steps back: PAR-13-358 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
- 4 steps back: PAR-13-029 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
Replaced by PAR-21-343.
Who won it before
50 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $26,388,191 in first-year total cost, median $527,029.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BDCN-L (60)]7
- Special Emphasis Panel[ZCA1 SRB-K (O2)]6
- Special Emphasis Panel[ZHL1 CSR-S (O1)]6
- Special Emphasis Panel[ZCA1 RTRB-4 (O1)]4
- Special Emphasis Panel[ZAI1 BLG-M (S1)]3
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL4
- CHILDREN'S RESEARCH INSTITUTE3
- MASSACHUSETTS GENERAL HOSPITAL3
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO3
- CASE WESTERN RESERVE UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)1U01HL156655-01A1 | BOUCHER, RICHARD CHARLESCHEN, GANG | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $748,549 | ZHL1 |
| 2022 | The role of inflammation in driving leukemogenesis in germline predisposition syndromes1U01CA257666-01A1 | AGARWAL, ANUPRIYABRESNICK, EMERY HGODLEY, LUCY ANNSPECK, NANCY | UNIVERSITY OF CHICAGO, IL | $707,850 | ZCA1 |
| 2022 | ATTRACT: Assessment of Temporomandibular JoinT MoRphology, Mechanics, And Mechanobiology in Class II and III Target and Surgical Phenotypes1U01DE031512-01 | LEE, JANICE SYAO, HAI | CLEMSON UNIVERSITY, SC | $620,600 | ZRG1 |
| 2022 | Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer1U01CA268933-01 | MADAN, RAVI AMRITTONER, MEHMET | MASSACHUSETTS GENERAL HOSPITAL, MA | $611,138 | ZCA1 |
| 2022 | Preclinical-Clinical Trials Collaboration to effectively advance new combination therapies for malignant peripheral nerve sheath tumors1U01CA268814-01 | CICHOWSKI, KAREN M | BRIGHAM AND WOMEN'S HOSPITAL, MA | $480,710 | ZCA1 |
| 2022 | A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)1U01CA268813-01 | CHANG, JENNY C-NLIPKOWITZ, STANLEYMERIC-BERNSTAM, FUNDAWONG, STEPHEN TC | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $448,905 | ZCA1 |
| 2022 | Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors1U01CA268806-01 | TRINCHIERI, GIORGIOZAROUR, HASSANE M | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $236,768 | ZCA1 |
| 2021 | Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children (MAGIC) Study1U01EY032403-01 | BROOKS, BRIAN PATRICKLUPO, PHILIP | BAYLOR COLLEGE OF MEDICINE, TX | $769,911 | ZRG1 |
| 2021 | Endometrial Basis for Infertility in Women with Recurrent Implantation Failure and Pregnancy Loss1U01HD104482-01 | DECHERNEY, ALAN H.SPENCER, THOMAS E | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $696,508 | ZRG1 |
| 2021 | Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease1U01HL156620-01 | DEBAUN, MICHAEL R.FITZHUGH, COURTNEY DFRIEDMAN, DEBRA L.JONES, RICHARD J | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $691,115 | ZHL1 |
| 2021 | Underlying Mechanisms in CADASIL1U01HL151203-01A1 | BOEHM, MANFREDIRUELA-ARISPE, M. LUISAKOZEL, BETH A | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $654,979 | ZHL1 |
| 2021 | Investigation and Treatment of Undiagnosed Neuroinflammatory Diseases1U01NS120836-01 | MISHRA, NISCHAYNATH, AVINDRAWILSON, MICHAEL R | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $617,274 | ZNS1 |
| 2021 | Quantifying and Personalizing the Clinical Benefit of Metastasis-Directed Therapy in Men with De Novo Oligometastatic Prostate Cancer1U01CA257638-01 | SPRATT, DANIEL EIDELBERGSUN, YILUN | CASE WESTERN RESERVE UNIVERSITY, OH | $513,265 | ZCA1 |
| 2020 | The Molecular and Genetic Pathogenesis of LAM2U01HL131022-04 | EL-CHEMALY, SOUHEILHENSKE, ELIZABETH P | BRIGHAM AND WOMEN'S HOSPITAL, MA | $877,667 | ZHL1 |
| 2020 | Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes1U01HL146188-01A1 | KOZEL, BETH AWILLIAMS, MARC S. | GEISINGER CLINIC, PA | $538,094 | ZHL1 |
| 2020 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas1U01CA247439-01 | TURAJLIC, SAMRA | FRANCIS CRICK INSTITUTE, LTD | $317,425 | ZCA1 |
| 2019 | Biologic correlatives of chronic GVHD onset1U01CA236229-01 · under PAR-18-646 | LEE, STEPHANIE JPAVLETIC, STEVEN | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $993,954 | ZCA1 |
| 2019 | Developing a Translation Pipeline for VHL Mutant Malignancies1U01CA236489-01 · under PAR-18-646 | LINEHAN, MARSTONMCDERMOTT, DAVIDSRINIVASAN, RAMAPRASAD | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $649,803 | ZCA1 |
| 2019 | Chemoprotection & Immune Remodeling after Hematopoietic Progenitor Cell Gene Therapy for Glioblastoma1U01CA236215-01 · under PAR-18-646 | GERSON, STANTON L.SLOAN, ANDREW E | CASE WESTERN RESERVE UNIVERSITY, OH | $565,191 | ZCA1 |
| 2019 | A collaborative approach to analyze and target the EWS-FLI1 transcription factor in patients with Ewing sarcoma1U01CA236220-01 · under PAR-18-646 | GROHAR, PATRICK J | SARC, MI | $473,617 | ZCA1 |
| 2018 | Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers1U01CA224766-01 · under PAR-15-287 | HEDRICK, CATHERINE CKAPLAN, ROSANDRASTRONCEK, DAVID FRANK | LA JOLLA INSTITUTE FOR IMMUNOLOGY, CA | $418,320 | ZCA1 |
| 2018 | Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses1U01AI122269-01A1 · under PAR-15-287 | BRATTON, DONNA LHOLLAND, STEVEN M | NATIONAL JEWISH HEALTH, CO | $166,582 | ZAI1 |
| 2017 | Evaluation of the Safety and Efficacy of Angiotensin 1-7 to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery1U01HL131014-01A1 · under PAR-15-287 | ARAI, ANDREW EHAY, MEREDITHRYAN, LEESWEITZER, NANCY K | UNIVERSITY OF ARIZONA, AZ | $745,065 | ZHL1 |
| 2017 | Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis1U01AI122275-01A1 · under PAR-15-287 | GALGIANI, JOHN NHOLLAND, STEVEN MLUSSIER, YVES A | UNIVERSITY OF ARIZONA, AZ | $573,884 | ZAI1 |
| 2017 | Intravenous delivery of 2-hydroxypropyl-Beta-cyclodextrin for treatment of Niemann-Pick C disease1U01HD090845-01 · under PAR-15-287 | ORY, DANIEL S | WASHINGTON UNIVERSITY, MO | $529,267 | ZRG1 |
| 2017 | SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF HIV-INFECTED CD4 T CELLS IN BLOOD AND LYMPHOID TISSUE USING PCR-ACTIVATED CELL SORTING1U01AI129206-01 · under PAR-15-287 | ABATE, ADAM R.BORITZ, ELI A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $481,092 | ZAI1 |
| 2017 | Optical and electromagnetic tracking guidance for hepatic interventions1U01CA202934-01A1 · under PAR-15-287 | MAHMOOD, UMAR | MASSACHUSETTS GENERAL HOSPITAL, MA | $421,989 | ZCA1 |
| 2017 | Bench to bedside: non-invasive treatment of tumors in children1U01CA202947-01A1 · under PAR-15-287 | KIM, PETER CWSHARMA, KARUN VWOOD, BRADFORD J | CHILDREN'S RESEARCH INSTITUTE, DC | $350,585 | ZCA1 |
| 2017 | Genetic Diagnosis of Childhood Growth Disorders1U01HD086838-01A1 · under PAR-15-287 | BARON, JEFFREYJEE, YOUN HEERADOVICK, SALLY | JOHNS HOPKINS UNIVERSITY, MD | $168,712 | ZRG1 |
| 2016 | The Molecular and Genetic Pathogensis of LAM1U01HL131022-01 · under PAR-13-358 | HENSKE, ELIZABETH P | BRIGHAM AND WOMEN'S HOSPITAL, MA | $754,946 | ZHL1 |
| 2016 | Developing a translational pipeline for NF1-mutant malignancies1U01CA202943-01 · under PAR-13-358 | CICHOWSKI, KAREN MWIDEMANN, BRIGITTE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $578,917 | ZCA1 |
| 2016 | Underlying Mechanisms of Vascular Disease1U01HL131019-01 · under PAR-13-358 | BOEHM, MANFREDIRUELA-ARISPE, M. LUISA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $524,790 | ZHL1 |
| 2016 | Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer1U01CA202939-01 · under PAR-13-358 | GULLEY, JAMES L.KANTOFF, PHILIP W | SLOAN-KETTERING INST CAN RESEARCH, NY | $470,524 | ZCA1 |
| 2016 | Microbial, immune, metabolic perturbations by antibiotics (MIME study)1U01AI122285-01 · under PAR-13-358 | BLASER, MARTIN J | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $423,750 | ZAI1 |
| 2015 | Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis1U01HD079066-01A1 · under PAR-13-358 | WOLFE, JOHN H | CHILDREN'S HOSP OF PHILADELPHIA, PA | $656,702 | ZRG1 |
| 2015 | Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant1U01AI115714-01 · under PAR-13-358 | MASUR, HENRYSTOCK, PETER G | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $601,291 | ZAI1 |
| 2015 | Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease1U01HL121842-01A1 · under PAR-13-358 | BYRNE, BARRY J | UNIVERSITY OF FLORIDA, FL | $601,129 | ZHL1 |
| 2015 | Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant1U01AI115711-01 · under PAR-13-358 | GRINSPOON, STEVEN K.HADIGAN, COLLEEN M | MASSACHUSETTS GENERAL HOSPITAL, MA | $587,655 | ZAI1 |
| 2015 | Beyond the reproductive tract: The future of Y chromosome research1U01HG007587-01A1 · under PAR-13-358 | MUENKE, MAXIMILIANPAGE, DAVID C. | WHITEHEAD INSTITUTE FOR BIOMEDICAL RES, MA | $487,619 | GNOM |
| 2015 | Cerebellar Structure and Function Studies in Very Early Abstinence1U01AA023674-01 · under PAR-13-358 | FEIN, GEORGE | NEUROBEHAVIORAL RESEARCH, INC., HI | $464,024 | ZRG1 |
| 2015 | Mucosal and Systemic Immune Responses to Influenza Virus1U01AI115715-01 · under PAR-13-358 | GREENBERG, HARRY BERNARD | PALO ALTO VETERANS INSTIT FOR RESEARCH, CA | $427,852 | ZAI1 |
| 2015 | PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics1U01CA183031-01A1 · under PAR-13-358 | DEWEESE, THEODORE LPOMPER, MARTIN G | JOHNS HOPKINS UNIVERSITY, MD | $410,209 | ZCA1 |
| 2015 | Antiretroviral Therapy in Aicardi Goutieres Syndrome1U01HD082806-01 · under PAR-13-358 | GAHL, WILLIAM ALLENVANDERVER, ADELINE LUCIE | CHILDREN'S RESEARCH INSTITUTE, DC | $288,019 | ZRG1 |
| 2015 | Single chain urokinase plasminogen activator (scuPA) for treatment of loculated complicated parapneumonic effusions and empyema1U01HL121841-01A1 · under PAR-13-358 | IDELL, STEVENMASUR, HENRYWOODS, CHRISTIAN J | UNIVERSITY OF TEXAS HLTH CTR AT TYLER, TX | $74,071 | ZHL1 |
| 2014 | MRI-safe 3Dl intracardiac ultrasound catheter for cardiovascular intervention1U01HL121838-01 · under PAR-13-029 | DEGERTEKIN, F. LEVENTLEDERMAN, ROBERT J | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $683,344 | ZHL1 |
| 2014 | Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML1U01CA183030-01 · under PAR-13-029 | LIU, YANGSCHORE, REUVEN J | CHILDREN'S RESEARCH INSTITUTE, DC | $653,666 | ZCA1 |
| 2014 | Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient1U01CA183012-01 · under PAR-13-029 | ZAIA, JOHN A | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $465,641 | ZCA1 |
| 2014 | Integrative molecular imaging and sequencing of prostate cancer1U01CA183027-01 · under PAR-13-029 | CHINNAIYAN, ARUL MLINEHAN, MARSTON | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $416,880 | ZCA1 |
| 2014 | Birth Defects: Moebius syndrome and related facial weakness disorders1U01HD079068-01 · under PAR-13-029 | BROOKS, BRIAN PATRICKENGLE, ELIZABETH C.JABS, ETHYLIN WANGMANOLI, IRINIPIERPAOLI, CARLO | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $388,120 | ZRG1 |
| 2014 | A Phase 1 Dose Escalation Study of Vorinostat in Niemann-Pick C1 Disease1U01HD079065-01 · under PAR-13-029 | MAXFIELD, FREDERICK R.ORY, DANIEL S | WASHINGTON UNIVERSITY, MO | $360,223 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.